PATENT CLAIM ANALYSIS

Application Number: 15925559
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "210190"]

Abstract:
The present invention relates to inhibitors of histone deacetylases, in particular HDAC8, that are useful for the treatment of cancer and other diseases and disorders, as well as the synthesis and applications of said inhibitors.

Claim (Index 58):
The composition of  claim 57 , wherein R c  is aryl optionally substituted with \u2014OR e .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15067605', '15255817', '11969975', '12734030', '15711794']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7698909645431655
- 35 USC 102 Novelty (BERT): 0.5624107410779581
- Combined Prediction Score: 0.7491429421966448
- Mean Citation Score: 337.928422
- Max Citation Score: 444.2229
- Similarity Product: 311.5567783323526

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test